Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide.

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

1992 • 9,540 citations

Cell Death: The Significance of Apoptosis

1980 • 7,281 citations

Apoptosis in the Pathogenesis and Treatment of Disease

1995 • 6,610 citations

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

1991 • 4,682 citations

The Fas Death Factor

1995 • 4,070 citations

Apoptosis. Its significance in cancer and cancer Therapy

1994 • 2,148 citations

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1995 • 2,028 citations

Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

1996 • 1,281 citations

A role for CD95 ligand in preventing graft rejection

1995 • 1,184 citations

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

1996 • 1,001 citations

Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?

1996 • 917 citations

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.

1996 • 894 citations

Fas ligand in human serum

1996 • 682 citations

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

1995 • 656 citations

Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

1993 • 643 citations

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.

1993 • 507 citations

Cell Death Mechanisms and the Immune System

1991 • 459 citations

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

1997 • 403 citations

Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.

1994 • 386 citations

Apoptosis and necrosis. Basic types and mechanisms of cell death.

1993 • 353 citations

Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells.

1994 • 309 citations

Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity.

1994 • 294 citations

Mechanism and Biological Significance of CD4‐mediated Cytotoxicity

1995 • 211 citations

Intralesional interferon therapy for basal cell carcinoma

1990 • 202 citations

Fas and the art of lymphocyte maintenance.

1996 • 196 citations

Treatment of basal cell carcinoma with intralesional interferon

1986 • 189 citations

Expression of Fas Antigen on Keratinocytes In Vivo and Induction of Apoptosis in Cultured Keratinocytes

1994 • 175 citations

Regression in basal cell carcinoma: an immunohistochemical analysis

1994 • 124 citations

Induction of apoptotic cell death in non‐melanoma skin cancer by interferon‐α

1995 • 107 citations

Biologic Effects of Interferons

1990 • 105 citations

Treatment of neoplastic skin lesions with intralesional interferon

1989 • 81 citations

Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines

1994 • 81 citations

Apoptosis in the immune system

1994 • 66 citations

Intralesional interferon alfa-2b in the treatment of basal cell carcinoma

1991 • 59 citations

Use of Recombinant Interferon Alfa-2b in the Treatment of Basal Cell Carcinoma

1995 • 56 citations

A role for CD95 ligand in preventing graft rejection

1996 • 54 citations

Interferon-γ-Dependent Stimulation of Fas Antigen in SV40-Transformed Human Keratinocytes: Modulation of the Apoptotic Process by Protein Kinase C

1995 • 50 citations

Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha2-interferon

1990 • 40 citations

Immunologic Effects of Interferon

1990 • 35 citations

Intralesional interferon-alpha 2b treatment of basal cell carcinoma.

1990 • 21 citations

Treatment of basal cell carcinomas with intralesional recombinant interferonα-2b

1991 • 9 citations

Apoptosis.

1994 • 8 citations

Normal Human Skin Lymphocytic and Langerhans’ Cell Responses to Intradermal Interferon α-2β Injections

1993 • 7 citations

Interferons: their role in clinical practice.

1995 • 6 citations